GlaxoSmithKline in China (C) Harvard Case Solution & Analysis

This case ensue GlaxoSmithKline (A), 514049 and GlaxoSmithKline (B), 514050. Four of the GlaxoSmithKline workforce were indicted of bribing Chinese health care human resources to advise the company's drugs.

The allegation brought to light the doubtful incentive structures of the Chinese health care system and the anxiety on corporation to adhere to local traditions while still observing local laws.

PUBLICATION DATE: January 16, 2014 PRODUCT #: 514092-PDF-ENG

This is just an excerpt. This case is about SALES & MARKETING

GlaxoSmithKline in China (C) Case Solution Other Similar Case Solutions like

GlaxoSmithKline in China (C)

Share This